McGuire Investment Group LLC Reduces Position in CME Group Inc. (NASDAQ:CME)

McGuire Investment Group LLC reduced its holdings in CME Group Inc. (NASDAQ:CME) by 0.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,730 shares of the financial services provider’s stock after selling 154 shares during the period. McGuire Investment Group LLC’s holdings in CME Group were worth $9,428,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Capital International Investors boosted its position in shares of CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after acquiring an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. boosted its holdings in CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after purchasing an additional 1,309,097 shares during the last quarter. M&G Plc purchased a new stake in shares of CME Group in the 1st quarter valued at approximately $156,631,000. Assenagon Asset Management S.A. increased its holdings in shares of CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after buying an additional 550,133 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its position in shares of CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after buying an additional 537,758 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Up 0.2 %

Shares of CME traded up $0.47 during midday trading on Friday, hitting $221.72. The company had a trading volume of 1,123,088 shares, compared to its average volume of 1,954,162. The company’s 50-day simple moving average is $214.61 and its 200-day simple moving average is $207.93. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $226.78. The firm has a market capitalization of $79.83 billion, a P/E ratio of 25.22, a P/E/G ratio of 7.76 and a beta of 0.55.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter in the previous year, the firm earned $2.30 earnings per share. The firm’s quarterly revenue was up 12.7% on a year-over-year basis. As a group, sell-side analysts expect that CME Group Inc. will post 10.04 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. Keefe, Bruyette & Woods raised their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday, July 25th. Citigroup raised their price objective on CME Group from $240.00 to $250.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Barclays upped their target price on shares of CME Group from $209.00 to $219.00 and gave the company an “equal weight” rating in a research report on Monday, October 7th. The Goldman Sachs Group lifted their price target on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday, October 3rd. Finally, TD Cowen assumed coverage on shares of CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective on the stock. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $217.71.

Insiders Place Their Bets

In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.